2'-deoxy-3'-adenosine monophosphate: inhibitor of adenylate cyclase; see also record for 2',5' cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
2'-deoxyadenosine 3'-monophosphate : A 2'-deoxyadenosine phosphate having a monophosphate group located at the 3'-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 167350 |
| CHEMBL ID | 513308 |
| CHEBI ID | 580387 |
| SCHEMBL ID | 3502762 |
| MeSH ID | M0090985 |
| Synonym |
|---|
| 2'-deoxy-adenosine 3'-monophosphate |
| 1CS4 |
| 2'-deoxy-3'-amp |
| 2'-deoxyadenosine 3'-monophosphate |
| CHEBI:580387 , |
| 2'-deoxy-3'-adenosine monophosphate |
| 15731-72-3 |
| 2'-deoxy-3'-adenylic acid |
| CHEMBL513308 |
| 2'-deoxyadenosine 3'-phosphate |
| [(2r,3s,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate |
| 3'-adenylic acid, 2'-deoxy- |
| 2'-deoxyadenosine 3'-monophosphate sodium salt |
| SCHEMBL3502762 |
| J-700036 |
| 2'-deoxyadenosine-3'-monophosphate, free acid (damp.h2) |
| 2'-deoxyadenosine-3'-monophosphate |
| (2r,3s,5r)-5-(6-amino-9h-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl dihydrogen phosphate |
| desoxyadenosin-3'-monophosphat |
| 9-(2-deoxy-3-o-phosphonopentofuranosyl)-9h-purin-6-amine |
| DTXSID10935657 |
| Q27105175 |
| 2'-deoxy-d-adenosine 3'-monophosphate sodium salt |
| 2/'-deoxyadenosine-3/'-monophosphate |
| A900763 |
| Class | Description |
|---|---|
| 2'-deoxyadenosine phosphate | |
| purine 2'-deoxyribonucleoside 3'-monophosphate | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, TYPE V ADENYLATE CYCLASE | Canis lupus familiaris (dog) | IC50 (µMol) | 2.7000 | 2.7000 | 2.7000 | 2.7000 | AID977608 |
| Chain B, TYPE II ADENYLATE CYCLASE | Rattus norvegicus (Norway rat) | IC50 (µMol) | 2.7000 | 2.7000 | 2.7000 | 2.7000 | AID977608 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID353131 | Inhibition of penicillin-resistant Streptococcus pneumoniae 159 recombinant MurM at 1 mM by liquid scintillation counting | 2009 | Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9 | Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors. |
| AID977608 | Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB | 2000 | Biochemistry, Nov-28, Volume: 39, Issue:47 | Molecular basis for P-site inhibition of adenylyl cyclase. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||